Blood test may predict prostate cancer drug success
NCT ID NCT01961843
First seen Jan 03, 2026 · Last updated May 21, 2026 · Updated 22 times
Summary
This study looked at whether a blood test can predict how prostate cancer responds to the drug abiraterone. Researchers collected blood samples from 40 men with advanced prostate cancer before and during treatment. They measured proteins in rare tumor cells found in the blood to see if these proteins could forecast treatment success. The goal was to develop a way to guide treatment without needing a biopsy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.